Your browser doesn't support javascript.
loading
ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPα.
Gonzalez, David; Luyten, Annouck; Bartholdy, Boris; Zhou, Qiling; Kardosova, Miroslava; Ebralidze, Alex; Swanson, Kenneth D; Radomska, Hanna S; Zhang, Pu; Kobayashi, Susumu S; Welner, Robert S; Levantini, Elena; Steidl, Ulrich; Chong, Gilbert; Collombet, Samuel; Choi, Min Hee; Friedman, Alan D; Scott, Linda M; Alberich-Jorda, Meritxell; Tenen, Daniel G.
Afiliação
  • Gonzalez D; From the Cancer Science Institute, National University of Singapore, 117599 Singapore.
  • Luyten A; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Bartholdy B; From the Cancer Science Institute, National University of Singapore, 117599 Singapore.
  • Zhou Q; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Kardosova M; From the Cancer Science Institute, National University of Singapore, 117599 Singapore.
  • Ebralidze A; the Institute of Molecular Genetics of the ASCR, Prague 142 20, Czech Republic.
  • Swanson KD; the Childhood Leukaemia Investigation Prague, Second Faculty of Medicine Charles University, University Hospital Motol, Prague 150 06, Czech Republic.
  • Radomska HS; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Zhang P; the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115.
  • Kobayashi SS; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Welner RS; The Ohio State University, Comprehensive Cancer Center, Columbus, Ohio 43210, and.
  • Levantini E; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Steidl U; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Chong G; the Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115.
  • Collombet S; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Choi MH; the Hematology/Oncology Department, University of Alabama at Birmingham, Birmingham, Alabama 35294.
  • Friedman AD; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Scott LM; the Institute of Biomedical Technologies, National Research Council, 56124 Pisa, Italy.
  • Alberich-Jorda M; the Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115.
  • Tenen DG; the Department of Cell Biology, and Department of Medicine (Oncology), Albert Einstein College of Medicine, New York, New York 10461.
J Biol Chem ; 292(46): 18924-18936, 2017 11 17.
Article em En | MEDLINE | ID: mdl-28900037
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Transcricional / Transativadores / Regiões Promotoras Genéticas / Células Mieloides / Proteína alfa Estimuladora de Ligação a CCAAT Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Transcricional / Transativadores / Regiões Promotoras Genéticas / Células Mieloides / Proteína alfa Estimuladora de Ligação a CCAAT Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2017 Tipo de documento: Article